Science
Mechanism of Action
This specialized IgG protein functions as a specific inhibitor of Matrix Metalloproteinase-1 (MMP-1), also known as interstitial collagenase. By binding precisely to the enzyme's active or allosteric sites, it effectively blocks the enzyme's ability to cleave the triple-helix structure of Type I collagen, preventing the breakdown of the skin's primary support fibers.
Research
Clinical Evidence
High confidence0.1%
Key findings
- 01 In vitro testing demonstrated a 90% inhibition of MMP-1 activity at a 0.1% concentration.
- 02 8-week consumer trials reported measurable improvements in skin elasticity and a visible reduction in the depth of fine lines.
Transparency
Dusting Analysis
Due to its complex manufacturing and high cost as a monoclonal antibody, this ingredient is frequently included at trace levels for marketing purposes. Efficacy is tied to the 0.1% threshold used in clinical validation; amounts significantly lower may fail to provide the necessary enzymatic blockade.
The Formula
Formulation
Stability
Extremely thermolabile; must be incorporated during the cool-down phase of production (below 40°C). As a large molecule (150 kDa), it requires advanced delivery systems like liposomes to effectively reach its target in the deeper skin layers.
Synergies
- Liposomal delivery systems
- Type I Collagen precursors
- Broad-spectrum antioxidants
Conflicts
- Strong acids
- Strong bases
- Heavy metals
- High heat (>40°C)
- High concentrations of ethoxylated surfactants
Safety
Safety Profile
Systemic absorption is negligible due to its high molecular weight. While protein-based contact dermatitis is a theoretical risk, it is reported as rare in clinical settings.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A highly potent and specific anti-aging tool that offers unmatched collagen protection when formulated at 0.1% within a stable, low-temperature delivery system.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources